BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 153652)

  • 1. [Results of immunization of seronegative children with live poliomyelitis vaccine].
    Babaev AA
    Vopr Virusol; 1978; (5):553-6. PubMed ID: 153652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of immunity to the poliomyelitis virus in infants with various methods of administering a live poliomyelitis vaccine].
    Drozdov SG; Zhevandrova VI; Smirnova GA; Shmel'kov IuA; Kodkind GKh
    Vopr Virusol; 1979; (3):252-9. PubMed ID: 223328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliomyelitis: epidemiology and prophylaxis. 5. Results of a two- and three-dose vaccination experiment.
    Metselaar D; McDonald K; Gemert W; van Rens MM; Muller AS
    Bull World Health Organ; 1977; 55(6):755-9. PubMed ID: 202418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The level of herd immunity against poliomyelitis in children during the mass vaccinal prophylaxis of this infection].
    Spynu KI; Buzdugan GI; Vutkarev VP
    Vopr Virusol; 1986; 31(5):602-5. PubMed ID: 3026095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poliomyelitis vaccination of infants: preimmunization status and seroconversion.
    Choudhury DS; Nossik NN; Bindu ; Vijayan P; Raghavan NG; Paul SS
    Bull World Health Organ; 1973; 48(2):195-8. PubMed ID: 4352611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of the dynamics of herd immunity to the poliovirus and of the quality of the vaccination carried out against poliomyelitis].
    Vlasova LV; Vaserin IuI; Stepanova GP; Zakirova SF; Venediktova NIa
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):75-8. PubMed ID: 6303022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possibility of occurrence of mild spinal forms of poliomyelitis in subjects immunized repeatedly with live poliomyelitis vaccine].
    Modestova NV; Dvoskina BIa; Nedel'ko NP; Astakhova AG; Zlobin VI
    Vopr Virusol; 1976; (2):154-8. PubMed ID: 936571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relative immunity to poliomyelitis in children from 0 to 10, after the 4th National Polio Vaccination Day with trivalent oral type Sabin vaccination, in the area of greater São Paulo, SP (Brazil), 1982].
    Barbosa V; Waldman EA; Fujita M; Kitamura C; Waldman CC; Lacerda JP
    Rev Saude Publica; 1984 Feb; 18(1):19-29. PubMed ID: 6328635
    [No Abstract]   [Full Text] [Related]  

  • 11. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
    Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
    JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Response of revaccination against polio I in seronegative children after receiving 3 or more doses of the vaccine].
    Ruiz-Gómez J; Sánchez Burgos Y; Arrayales Sandoval F; Velázquez Zúñiga C
    Gac Med Mex; 1977 Jan; 113(1):23-7. PubMed ID: 863152
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indicators of immunity in children vaccinated with live poliomyelitis vaccine].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):115-7. PubMed ID: 204133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamics of secretory and serum immunoglobulins in children in the course of vaccinations with live poliomyelitis monovaccines].
    Shmel'kov IuA; Zhevandrova VI; Drozdov SG
    Vopr Virusol; 1978; (3):332-6. PubMed ID: 358597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for a national policy on poliomyelitis vaccination.
    Nightingale EO
    N Engl J Med; 1977 Aug; 297(5):249-53. PubMed ID: 195207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Humoral poliomyelitis immunity in children inoculated with a live poliomyelitis vaccine].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
    Vopr Virusol; 1984; 29(2):251-3. PubMed ID: 6328770
    [No Abstract]   [Full Text] [Related]  

  • 19. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.